Using female Balb/C mice and syngeneic mammary tumor cells (67NR, 4T1, 4T07), the authors demonstrated that peripheral tumor growth promotes systemic inflammation, largely driven by interleukin-6 (IL-6). This evidence concerns the gene IL6 and neoplasm.